Want to create an interactive transcript for this episode?
Podcast: Thoughts on the Market
Episode: 5 Reasons the Obesity Drug Market Remains Strong
Description: The global market for obesity drugs is expanding. Our U.S. Pharma and Biotech Analyst Terrence Flynn discusses what’s driving the next stage of global growth for GLP-1 medicines.Read more insights from Morgan Stanley.----- Transcript -----Terrence Flynn: Welcome to Thoughts on the Market. I'm Terrence Flynn, Morgan Stanley's U.S. Pharma and Biotech Analyst. The market for obesity medicines is at an inflection point, and today I'll focus on what's driving the next stage of global growth.It's Thurs...